WednesdayJul 27, 2022 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Set to Capitalize on Lidar Sector’s Exponential Growth Trends

Originally designed to map out the meteorology of early weather, lidar sensor technology has powered/enabled a wide range of innovative applications The rapid development and adoption of lidar technology is expected to drive the sector to grow to a value of EUR 50 billion per annumCepton, Inc. has been a key beneficiary of sectoral growth, having earlier been awarded the largest ADAS lidar contract by an automotive OEM in historyThe company has also pioneered the usage of lidar technology in alternative applications worldwide, recently collaborating with Fibre Based Integrations to revamp Cape Town’s traffic infrastructure using their proprietary technology In the…

Continue Reading

TuesdayJul 26, 2022 1:00 pm

Golden Matrix Group Inc. (NASDAQ: GMGI) Reports Fastest 1QFY2022 Revenue Growth within the Online Gaming Sector

Golden Matrix Group recorded revenue growth of +355% YoY in 1QFY22, the highest growth rate within the online gaming sector Golden Matrix attributed part of the increase to strong revenue contributions from UK-based RKingsCompetitions Ltd, which it purchased an 80% stake in as of November 2021RKings has emerged as one of the UK’s largest online competition companies, reporting revenues of over $32 million last yearThe acquisition of RKings bodes favourably for GMGI’s bid to further expand their B2C segment whilst geographically diversifying their revenue stream away from their traditional Asia-Pacific based B2B clientele The online gaming market is on a roll.…

Continue Reading

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patentsRecently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in JapanThe patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent familyLexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our proprietary technology… I…

Continue Reading

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine monthsThe pivotal study was designed with four primary objectivesCybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://ibn.fm/2Ab0T). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004.  “With the closing of this transaction we are…

Continue Reading

FridayJul 22, 2022 10:00 am

Looking for an Edge? Golden Matrix Group Inc. (NASDAQ: GMGI) to Release Peer-to-Peer Esports Betting Product

GMGI CEO says new P2P Esports offering coming “quite soon”Gaming operators have need for new products to grow market shareNew product overcomes challenges related to compliance in Esports gambling If you’re paying attention to the sports betting market, you’re seeing companies big and small looking for edges to capture market share from competition in a fierce, albeit huge, marketplace. It’s tough to carve out profits when, in the words of Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI), “everyone [is] fishing in the same pond.” Companies must be differentiated, as is Golden Matrix, a provider of turnkey and white…

Continue Reading

ThursdayJul 21, 2022 11:15 am

Mullen Automotive Inc. (NASDAQ: MULN) Recently Featured on Benzinga, Noting Solid-State Battery Test Results that Exceed Expectations, Extend EV Range

MULN shares traded higher after Benzinga stated that the emerging EV manufacturer had reported higher-than-expected battery test resultsData shows the company’s proprietary solid-state polymer batteries can deliver more than 600 miles of range on a full chargeThe company plans to include the new batteries in its second-generation Mullen FIVE EV Crossover Mullen Automotive (NASDAQ: MULN) was featured in a recent Benzinga Brief. The short summary noted that the company, an emerging electric-vehicle manufacturer, had reported results of its solid-state polymer battery testing, which exceeded expectations (https://ibn.fm/XI6Fa). Noting that shares were trading higher after the news, Benzinga quoted David Michery, Mullen…

Continue Reading

WednesdayJul 20, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pending Start of Human Nicotine Study, NIC-H22-1, Leveraging Fast-Growing Global Nicotine Pouches Market

Lexaria Bioscience Corp. expects the upcoming human nicotine study to produce evidence that its patented DehydraTECH(TM) technology can enhance oral-tissue absorption with reduced negative experiencesData collected from animal study NIC-A21-1 showed that DehydraTECH enhanced oral nicotine pouches delivered peak nicotine levels in the bloodstream of animals 10x to 20x faster than the controlThe global nicotine pouches market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, being one of the fastest growing segments in the nicotine industryLexaria's pipeline addresses serious unmet patient or consumer needs with greater market potential, addressing multiple mainstream applications…

Continue Reading

TuesdayJul 19, 2022 9:45 am

QSAM Biosciences Inc. (QSAM) Marks Milestone with Dosing of First Patient in CycloSam Clinical Trial

Treating patients with primary or secondary bone cancer remains goal, says company CEORadiopharmaceuticals is a new class of drugs that delivers radiation therapy directly to cancer cellsQSAM is working to develop CycloSam(R) as a breakthrough therapeutic for adult and pediatric bone cancer patients QSAM Biosciences (OTCQB: QSAM), a company developing a new class of drugs called radiopharmaceuticals, is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical…

Continue Reading

MondayJul 18, 2022 11:15 am

Cepton, Inc. (NASDAQ: CPTN) Furthers Tier 1 Collaboration, Aims to Make Lidar a Standard Feature in Transportation

CPTN produces near-range to ultra-long-range lidar sensors, perception solutions, and software for leading OEM manufacturers across the automotive and smart infrastructure marketsCepton aims to make lidar standard in every vehicle to enable safe assisted driving and autonomyCPTN's collaboration with Japan-based Koito Manufacturing Co. Ltd. led to ADAS lidar series production award from General MotorsCepton lidar sensors to be used in upcoming GM models featuring its Ultra Cruise advanced driver-assist system starting next year Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, aims to make its proprietary technology standard in all consumer vehicles to support…

Continue Reading

MondayJul 18, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Best-In Class Solution To Major Issue Affecting A Range Of Critical Drug Applications

Researchers have run into the issue of solubility of molecules intended for absorption, ultimately affecting drug effectiveness and inhibiting patient recoveryThis has forced the exploration of new drug delivery technologies, with Lexaria’s patented DehydraTECH(TM) technology proving to be the most innovative, useful, and effectiveDehydraTECH(TM) technology has seen application in oral nicotine for reduced risk, antiviral drugs for COVID-19 and other infectious diseases, PDE5 inhibitors, and CBD for hypertensionThe recent expansion of the Cannadips Brand into Europe, Japan, and South Africa highlights the proliferation of DehydraTECH and a significant growth in its market share, particularly in the CBD spaceLexaria is excited…

Continue Reading

Contact us: (310) 299-1717